I
CMPX icon

INVST’s Compass Therapeutics CMPX Stock Holding History

INVST’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$84.6K Buy
+16,000
New +$92.4K 0.01% 325

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

INVST's CMPX Position: Q1 2026 in Review

INVST opened a new position in Compass Therapeutics (CMPX) in Q1 2026: 16,000 shares worth $84.6K. The stake represents 0.01% of the portfolio and ranks #325 among its holdings.

201 funds tracked by Wall St. Rank hold CMPX as of Q1 2026.

  • INVST held 16,000 shares of Compass Therapeutics worth $84.6K as of Q1 2026.
  • Compass Therapeutics was a new INVST position in Q1 2026.
  • Compass Therapeutics made up 0.01% of INVST's portfolio in Q1 2026, its #325 holding.
  • 201 funds tracked by Wall St. Rank held Compass Therapeutics as of Q1 2026.

Based on INVST's 13F filing for Q1 2026, filed 13 May 2026.